TMCnet News
Crinetics Pharmaceuticals to Participate in the Piper Jaffray Healthcare ConferenceSAN DIEGO, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference. The discussion will take place on Wednesday, December 4, 2019 at 11:30 a.m. ET (8:30 a.m. PT) in New York City. A live audio webcast and replay of the event will be available in the Investors section on the company’s website at www.crinetics.com. About Crinetics Pharmaceuticals Contacts: Robert H. Uhl |